AU Patent

AU2023314771A1 — Ophthalmic topical cream formulations and uses thereof

Assigned to Glaukos Corp · Expires 2025-02-13 · 1y expired

What this patent protects

Described herein are topical cream formulations that include a C

USPTO Abstract

Described herein are topical cream formulations that include a C

Drugs covered by this patent

oxymetazoline-hydrochloride (OXYMETAZOLINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2023314771A1
Jurisdiction: AU
Classification: —
Expires: 2025-02-13
Drug substance claim: No
Drug product claim: No
Assignee: Glaukos Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.